Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator

Chitladda Mahanivong, Jianqiang Yu, Shuang Huang

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Urokinase plasminogen activator (uPA) and its receptor (uPAR) are overexpressed in various neoplasms, and play a key role in tumor progression and metastasis. In this study, we examined uPA and uPAR expression in a variety of human breast cancer cell lines and found that lines with elevated uPA expression also exhibited high uPAR expression, suggesting the possibility that uPA and uPAR are regulated in concert. To test this possibility, we introduced antisense uPA RNA and antisense uPAR RNA in MDA-MB-231 and BT-549 lines that express high levels of uPA and uPAR. Antisense uPA RNA not only downregulated uPA expression, but also greatly reduced uPAR expression in both lines. However, antisense uPAR RNA-reduced uPAR expression with no apparent inhibitory effect on the levels of uPA. These results indicate that expression of uPAR requires uPA but not vice versa. With a panel of uPA and uPAR monoclonal antibodies (mAbs), we observed that the mAbs disrupting uPA and uPAR interaction, rather than mAb inhibiting uPA protease activity, reduced uPAR expression. Moreover, adding soluble single chain uPA (scuPA) to MDA-MB-231 or BT-549 cells expressing antisense uPA mRNA-restored uPAR expression. These findings suggest that uPA dictates uPAR expression and that uPA binding to uPAR transmits signals for uPAR expression. Finally, we provided evidence that Fyn, a Src family kinase, is involved in uPA-induced uPAR expression.

Original languageEnglish (US)
Pages (from-to)165-175
Number of pages11
JournalMolecular Carcinogenesis
Volume46
Issue number3
DOIs
StatePublished - Mar 1 2007

Fingerprint

Plasminogen Activators
Urokinase-Type Plasminogen Activator
Urokinase Plasminogen Activator Receptors
RNA
Monoclonal Antibodies
Antisense RNA
src-Family Kinases

Keywords

  • Breast cancer cells
  • Metastasis
  • Proteolytic enzyme

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research

Cite this

Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator. / Mahanivong, Chitladda; Yu, Jianqiang; Huang, Shuang.

In: Molecular Carcinogenesis, Vol. 46, No. 3, 01.03.2007, p. 165-175.

Research output: Contribution to journalArticle

@article{1e5deb6088154e9387b84b60213e2e4e,
title = "Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator",
abstract = "Urokinase plasminogen activator (uPA) and its receptor (uPAR) are overexpressed in various neoplasms, and play a key role in tumor progression and metastasis. In this study, we examined uPA and uPAR expression in a variety of human breast cancer cell lines and found that lines with elevated uPA expression also exhibited high uPAR expression, suggesting the possibility that uPA and uPAR are regulated in concert. To test this possibility, we introduced antisense uPA RNA and antisense uPAR RNA in MDA-MB-231 and BT-549 lines that express high levels of uPA and uPAR. Antisense uPA RNA not only downregulated uPA expression, but also greatly reduced uPAR expression in both lines. However, antisense uPAR RNA-reduced uPAR expression with no apparent inhibitory effect on the levels of uPA. These results indicate that expression of uPAR requires uPA but not vice versa. With a panel of uPA and uPAR monoclonal antibodies (mAbs), we observed that the mAbs disrupting uPA and uPAR interaction, rather than mAb inhibiting uPA protease activity, reduced uPAR expression. Moreover, adding soluble single chain uPA (scuPA) to MDA-MB-231 or BT-549 cells expressing antisense uPA mRNA-restored uPAR expression. These findings suggest that uPA dictates uPAR expression and that uPA binding to uPAR transmits signals for uPAR expression. Finally, we provided evidence that Fyn, a Src family kinase, is involved in uPA-induced uPAR expression.",
keywords = "Breast cancer cells, Metastasis, Proteolytic enzyme",
author = "Chitladda Mahanivong and Jianqiang Yu and Shuang Huang",
year = "2007",
month = "3",
day = "1",
doi = "10.1002/mc.20249",
language = "English (US)",
volume = "46",
pages = "165--175",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator

AU - Mahanivong, Chitladda

AU - Yu, Jianqiang

AU - Huang, Shuang

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Urokinase plasminogen activator (uPA) and its receptor (uPAR) are overexpressed in various neoplasms, and play a key role in tumor progression and metastasis. In this study, we examined uPA and uPAR expression in a variety of human breast cancer cell lines and found that lines with elevated uPA expression also exhibited high uPAR expression, suggesting the possibility that uPA and uPAR are regulated in concert. To test this possibility, we introduced antisense uPA RNA and antisense uPAR RNA in MDA-MB-231 and BT-549 lines that express high levels of uPA and uPAR. Antisense uPA RNA not only downregulated uPA expression, but also greatly reduced uPAR expression in both lines. However, antisense uPAR RNA-reduced uPAR expression with no apparent inhibitory effect on the levels of uPA. These results indicate that expression of uPAR requires uPA but not vice versa. With a panel of uPA and uPAR monoclonal antibodies (mAbs), we observed that the mAbs disrupting uPA and uPAR interaction, rather than mAb inhibiting uPA protease activity, reduced uPAR expression. Moreover, adding soluble single chain uPA (scuPA) to MDA-MB-231 or BT-549 cells expressing antisense uPA mRNA-restored uPAR expression. These findings suggest that uPA dictates uPAR expression and that uPA binding to uPAR transmits signals for uPAR expression. Finally, we provided evidence that Fyn, a Src family kinase, is involved in uPA-induced uPAR expression.

AB - Urokinase plasminogen activator (uPA) and its receptor (uPAR) are overexpressed in various neoplasms, and play a key role in tumor progression and metastasis. In this study, we examined uPA and uPAR expression in a variety of human breast cancer cell lines and found that lines with elevated uPA expression also exhibited high uPAR expression, suggesting the possibility that uPA and uPAR are regulated in concert. To test this possibility, we introduced antisense uPA RNA and antisense uPAR RNA in MDA-MB-231 and BT-549 lines that express high levels of uPA and uPAR. Antisense uPA RNA not only downregulated uPA expression, but also greatly reduced uPAR expression in both lines. However, antisense uPAR RNA-reduced uPAR expression with no apparent inhibitory effect on the levels of uPA. These results indicate that expression of uPAR requires uPA but not vice versa. With a panel of uPA and uPAR monoclonal antibodies (mAbs), we observed that the mAbs disrupting uPA and uPAR interaction, rather than mAb inhibiting uPA protease activity, reduced uPAR expression. Moreover, adding soluble single chain uPA (scuPA) to MDA-MB-231 or BT-549 cells expressing antisense uPA mRNA-restored uPAR expression. These findings suggest that uPA dictates uPAR expression and that uPA binding to uPAR transmits signals for uPAR expression. Finally, we provided evidence that Fyn, a Src family kinase, is involved in uPA-induced uPAR expression.

KW - Breast cancer cells

KW - Metastasis

KW - Proteolytic enzyme

UR - http://www.scopus.com/inward/record.url?scp=33947098970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947098970&partnerID=8YFLogxK

U2 - 10.1002/mc.20249

DO - 10.1002/mc.20249

M3 - Article

VL - 46

SP - 165

EP - 175

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 3

ER -